The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Metabolic Depression: A Chronic Depressive Subtype? Findings From the InCHIANTI Study of Older Persons
Open accessAbstract
OBJECTIVE: Several studies report a cross-sectional association between metabolic syndrome and depression. Possibly, metabolic syndrome promotes onset or chronicity of depression. However, such a longitudinal link has not yet been confirmed. This study examines whether metabolic syndrome or its components are associated with onset and chronicity of depression. METHOD: Secondary analyses were performed on data from 823 participants (≥ 65 years of age) in the InCHIANTI study, a prospective, population-based cohort study of older persons. From 1998 to 2000, the study sample was randomly selected from the population registry of 2 sites in Italy using a multistage stratified sampling method. Baseline data collection consisted of a home interview and a medical evaluation at the study clinic. Follow-up for each participant occurred after 3 years and 6 years. Metabolic syndrome at baseline was defined as ≥ 3 of the following: abdominal obesity, high triglycerides, low high-density lipoprotein cholesterol, high blood pressure, and high fasting glucose. Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression scale (CES-D) at baseline and after 3 and 6 years. Sample characteristics were compared between persons with and without depression at baseline using χ² and t statistics. Logistic regression analyses were conducted separately in persons with and without depression at baseline to test whether metabolic syndrome at baseline could predict onset and chronicity of depression at follow-up. RESULTS: At baseline, 235 persons had metabolic syndrome, and 168 were depressed (CES-D score ≥ 20). Among persons not depressed at baseline, 26.0% developed depression. Higher waist circumference increased the odds of depression onset (adjusted OR per SD increase = 1.28; 95% CI, 1.05-1.56), but there was no association between other metabolic syndrome components and onset of depression. Among persons depressed at baseline, depression had a chronic character in 69.0% of persons without and 88.5% of persons with metabolic syndrome. Metabolic syndrome was associated with an almost 3-fold increase in the odds of chronicity of depression (adjusted OR = 2.66; 95% CI, 1.01-7.00), with almost every metabolic syndrome component contributing to this association. CONCLUSION: In late life, waist circumference, but not metabolic syndrome, predicted onset of depression. Depressed persons with metabolic syndrome were more likely to have persistent or recurrent depression. The latter may suggest that depression with metabolic abnormalities, which could be labeled metabolic depression, identifies a chronic subtype of depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Neurocognitive impairment is a relevant factor in patients' quality of life as it is negatively associated with psychosocial functioning in MDD 213 .”
From Major depressive disorder (2016) · cites this paper as [213]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Compendium of Physical Activities: Classification of energy costs of human physical activities
AINSWORTH, B. E., HASKELL, W. L., LEON, A. S., JACOBS, D. R., MONTOYE, H. J., SALLIS, J. F., & PAFFENBARGER, R. S. (1993) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199301000-00011 · Cited by 4,102
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
'Vascular Depression' Hypothesis
Alexopoulos, G. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830220033006 · Cited by 1,843
Nicholson, A., Kuper, H., & Hemingway, H. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl338 · Cited by 1,353 · cited 2×
“Metabolic syndrome was defined according to the National Cholesterol Education Program Adult Treatment Panel III guidelines4 as having 3 or more of the following criteria: (1) waist circumference ≥102 cm in men or ≥ 88 cm in women; (2) triglyceride level ≥150 mg/dL; (3) high-density lipoprotein cholesterol < 40 mg/dL…”
BackgroundMethodReview of community prevalence of depression in later life
Beekman, A. T. F., Copeland, J., & Prince, M. J. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.174.4.307 · Cited by 1,144
Self-citation
Research works printed but not linked: 2
- [26]Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1(3):385–401. [Google Scholar]
- [33]WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical Classification Geneva, Switzerland: World Health Organization; 2007. [Google Scholar]
Cited by
Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
Self-citationDepression and obesity: evidence of shared biological mechanisms
Milaneschi, Y., Simmons, W. K., van Rossum, E. F. C., & Penninx, B. W. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0017-5 · Cited by 1,073
Self-citationPenninx, B. W., Milaneschi, Y., Lamers, F., & Vogelzangs, N. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-129 · Cited by 839
“One longitudinal study among depressed patients found that a combination of multiple metabolic dysregulations contributed to chronicity of depression [33].”
BackgroundSelf-citationDepression and cardiovascular disease: Epidemiological evidence on their linking mechanisms
Penninx, B. W. J. H. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.07.003 · Cited by 576
Self-citationMetabolic syndrome in psychiatric patients: overview, mechanisms, and implications
Penninx, B. W. J. H., & Lange, S. M. M. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.1/bpenninx · Cited by 566
Self-citationMansur, R. B., Brietzke, E., & McIntyre, R. S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.12.017 · Cited by 322
Metabolic syndrome and major depression
Marazziti, D., Rutigliano, G., Baroni, S., Landi, P., & Dell'Osso, L. (2014) · CNS Spectrums · doi:10.1017/s1092852913000667 · Cited by 210
“It has been suggested that depression with metabolic abnormalities, labeled ‘‘metabolic depression,’’ may identify a chronic subtype of depression.(48) Recently, different clinical subtypes of depression were associated with specific clinical or laboratory abnormalities.”
BackgroundMetabolic and inflammatory markers: associations with individual depressive symptoms
Lamers, F., Milaneschi, Y., de Jonge, P., Giltay, E. J., & Penninx, B. W. J. H. (2018) · Psychological Medicine · doi:10.1017/s0033291717002483 · Cited by 193
Self-citationde Melo, L. G. P., Nunes, S. O. V., Anderson, G., Vargas, H. O., Barbosa, D. S., Galecki, P., Carvalho, A. F., & Maes, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.027 · Cited by 189
Metabolic Profile and Long-Term Risk of Depression, Anxiety, and Stress-Related Disorders
Chourpiliadis, C., Zeng, Y., Lovik, A., Wei, D., Valdimarsdóttir, U., Song, H., Hammar, N., & Fang, F. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.4525 · Cited by 164
Papakostas, G. I., Shelton, R. C., Zajecka, J., Bottiglieri, T., Roffman, J. L., Cassiello-Robbins, C. F., Stahl, S. M., & D, M. F. M. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08947 · Cited by 143
Vogelzangs, N., Beekman, A. T., van Reedt Dortland, A. K., Schoevers, R. A., Giltay, E. J., de Jonge, P., & Penninx, B. W. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.9 · Cited by 133
“…antidepressants in a subgroup of patients may be further evidence of the existence of an etiologically different subtype of depression with inflammatory and metabolic dysregulation, which is clinically relevant and which we have previously labeled ‘metabolic depression’ (Vogelzangs et al, 2011).”
BackgroundMethodInfluentialSelf-citationHamer, M., Batty, G. D., & Kivimaki, M. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.30 · Cited by 132
Dinga, R., Marquand, A. F., Veltman, D. J., Beekman, A. T. F., Schoevers, R. A., van Hemert, A. M., Penninx, B. W. J. H., & Schmaal, L. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0289-1 · Cited by 125
Self-citationSleep Duration, but Not Insomnia, Predicts the 2-Year Course of Depressive and Anxiety Disorders
van Mill, J. G., Vogelzangs, N., Someren, E. J. W. V., Hoogendijk, W. J. G., & Penninx, B. W. J. H. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m08047 · Cited by 122
“Especially in atypical depression, a different psychopathology may exist with more metabolic abnormalities and inflammation than in non-atypical depression (32), which in turn could unfavorably impact on course of disorders (33).”
BackgroundSelf-citationHermida, A. P., McDonald, W. M., Steenland, K., & Levey, A. I. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.127 · Cited by 118
Heritability of metabolic syndrome traits in a large population-based sample
van Dongen, J., Willemsen, G. A. H. M., Chen, W., de Geus, E. J. C., & Boomsma, D. I. (2013) · Journal of Lipid Research · doi:10.1194/jlr.p041673 · Cited by 113
Stability and transitions of depressive subtypes over a 2-year follow-up
Lamers, F., Rhebergen, D., Merikangas, K. R., de Jonge, P., Beekman, A. T. F., & Penninx, B. W. J. H. (2012) · Psychological Medicine · doi:10.1017/s0033291712000141 · Cited by 99
“A previous study that linked metabolic abnormalities and depression suggested that such a subtype of depression could be labeled as ‘metabolic depression’ (Vogelzangs et al. 2011), but more research is needed to warrant such a label.”
BackgroundSelf-citationWoo, Y., Seo, H.-J., McIntyre, R., & Bahk, W.-M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010080 · Cited by 79
“As obesity is a core feature of metabolic syndrome [167], the concept of “metabolic-mood syndrome” suggested by some authors [74,168,169] could be expanded to include the association between obesity and antidepressant responses.”
BackgroundSchizophrenia and type 2 diabetes mellitus
Mamakou, V., Thanopoulou, A. C., Gonidakis, F., Tentolouris, N., & Kontaxakis, V. P. (2018) · Psychiatriki · doi:10.22365/jpsych.2018.291.64 · Cited by 84
MAJOR DEPRESSIVE DISORDER SUBTYPES TO PREDICT LONG-TERM COURSE
van Loo, H. M., Cai, T., Gruber, M. J., Li, J., de Jonge, P., Petukhova, M. V., Rose, S., Sampson, N. A., Schoevers, R. A., Wardenaar, K. J., et al. (2014) · Depression and Anxiety · doi:10.1002/da.22233 · Cited by 73
“It would be interesting for future research to examine the possibility that the significant association found here between later-AOO anxious–suicidal depression in the index episode with later chronicity but no other outcome might reflect the importance of a late-onset depression subtype that might occur in conjunctio…”
BackgroundCarney, R. M., & Freedland, K. E. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3182405ac4 · Cited by 73
“Depression may be part of a broader network of cardiac risk factors, such as the metabolic syndrome (40,41), and it may increase the risk for cardiac events by adding to the burden of the proinflammatory and procoagulant processes and the CV autonomic dysregulation that are associated with both depression and with oth…”
BackgroundDepression and metabolic syndrome in the older population: A review of evidence
Repousi, N., Masana, M. F., Niubo, A. S., Haro, J. M., & Tyrovolas, S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.102 · Cited by 83
“Depression The majority of the studies (Akbaraly et al., 2011; Mast et al., 2008; Vogelzangs et al., 2011; Vogelzangs et al., 2007a; Vogelzangs et al., 2007b; Vogelzangs et al., 2009; Park et al., 2014) used the CES-D (Radloff, 1977) to assess depressive symptoms.”
BackgroundMethodInfluentialCircadian Clocks as Modulators of Metabolic Comorbidity in Psychiatric Disorders
Barandas, R., Landgraf, D., McCarthy, M. J., & Welsh, D. K. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0637-2 · Cited by 70
Depression and risk of type 2 diabetes: the potential role of metabolic factors
Schmitz, N., Deschênes, S. S., Burns, R. J., Smith, K. J., LESAGE, A. D., Strychar, I. M., RABASA-LHORET, R. P. R., Freitas, C., Graham, E. A., Awadalla, P., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.7 · Cited by 77
Brain-immune crosstalk in the treatment of major depressive disorder
Branchi, I., Poggini, S., Capuron, L., Benedetti, F., Poletti, S., Tamouza, R., Drexhage, H. A., Penninx, B. W. J. H., & Pariante, C. M. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.016 · Cited by 71
Self-citationMetabolic dysregulation and late-life depression: a prospective study
Marijnissen, R. M., Vogelzangs, N., Mulder, M., van den Brink, R. H. S., Comijs, H. C., & Voshaar, R. C. O. (2016) · Psychological Medicine · doi:10.1017/s0033291716003196 · Cited by 64
“This contrasts with findings in an older population-based sample showed that all components of MS contributed to the persistence of elevated depressive symptom scores (Vogelzangs et al. 2011).”
BackgroundResultInfluentialSelf-citationBiella, M. M., Borges, M. K., Strauss, J., Mauer, S., Martinelli, J. E., & Aprahamian, I. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s223640 · Cited by 57
“symptoms (InChianti study).(36) Finally, an interview with the caregiver or family informant can be necessary in cases of depression with cognitive symptoms and/or underreporting of depressive symptoms by the elder.”
Gao, W., Wang, W., Zhang, J., Deng, P., Hu, J., Yang, J. M., & Deng, Z. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00443-y · Cited by 55
Han, K., Kim, M. S., Kim, A., Paik, J., Lee, J., & Ham, B. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.07.003 · Cited by 47
Morikawa, M., Okamoto, N., Kiuchi, K., Tomioka, K., Iwamoto, J., Harano, A., Saeki, K., Fukusumi, M., Hashimoto, K., Amano, N., et al. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3950 · Cited by 42
“Recently, there have been six reports (three crosssectional and three cohort studies) (Laudisio et al., 2009; Vogelzangs et al., 2007a; Vogelzangs et al., 2007b; Vogelzangs et al., 2011; Almeida et al., 2009; Akbaraly et al., 2011) about MetS and depressive syndromes limited to the older people (≥65 years) in western…”
BackgroundAssociation between metabolic syndrome and depressive symptom profiles—Sex-specific?
Marijnissen, R. M., Smits, J., Schoevers, R. A., van den Brink, R. H. S., Holewijn, S., Franke, B., Graaf, J. D., & Voshaar, R. C. O. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.07.029 · Cited by 42
Chou, K., & Yu, K.-M. (2013) · Depression and Anxiety · doi:10.1002/da.22098 · Cited by 42
Sekita, A., Arima, H., Ninomiya, T., Ohara, T., Doi, Y., Hirakawa, Y., Fukuhara, M., Hata, J., Yonemoto, K., Ga, Y., et al. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-862 · Cited by 39
“Although a number of observational studies have investigated the association between MetS and depressive symptoms, their conclusions have been inconsistent [11-29].”
BackgroundWildisen, L., Feller, M., Del Giovane, C., Moutzouri, E., Du Puy, R. S., Mooijaart, S. P., Collet, T.-H., Poortvliet, R. K. E., Kearney, P., Quinn, T. J., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.36645 · Cited by 36
Kim, H.-B., Wolf, B. J., & Kim, J. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.11.049 · Cited by 37
Mulvahill, J. S., Nicol, G. E., Dixon, D. J., Lenze, E. J., Karp, J. F., Reynolds, C. F., Blumberger, D. M., & Mulsant, B. H. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15129 · Cited by 38
Targeting Metabolic Dysfunction for the Treatment of Mood Disorders: Review of the Evidence
Jones, B. D. M., Farooqui, S., Kloiber, S. M., Husain, M. O., Mulsant, B. H., & Husain, M. I. (2021) · Life · doi:10.3390/life11080819 · Cited by 36
Depressive symptom profiles, cardio-metabolic risk and inflammation: Results from the MIDUS study
Chirinos, D. A., Murdock, K. W., LeRoy, A. S., & Fagundes, C. P. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.04.011 · Cited by 36
“Furthermore, as suggested by some authors, depressive symptoms may not be the principal contributors to elevated cardio-metabolic risk, but rather may increase the risk by adding to the burden of pro-inflammatory cytokines (Vogelzangs et al., 2011).”
Wildisen, L., Giovane, C. D., Moutzouri, E., Beglinger, S., Syrogiannouli, L., Collet, T., Cappola, A. R., Åsvold, B. O., Bakker, S. J. L., Yeap, B. B., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-75776-1 · Cited by 40
Self-citationProbiotics therapy show significant improvement in obesity and neurobehavioral disorders symptoms
Cai, Y., Liu, P., Zhou, X., Yuan, J., & Chen, Q. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1178399 · Cited by 39
“AD Alzheimer’s disease AF Abdominal fat AKK Akkermansia muciniphila BAs Bile acids BBB Blood-brain barrier BDNF Brain-derived neurotrophic factor BMI Body mass index CCL2 C-C motif chemokine 2 CCO Cytochrome c oxidase CNS Central nervous system DAO Diamine oxidase DCA Deoxycholic acid D3-5 Lactobacillus paracasei D3-5…”
BackgroundInfluentialMahboobi, S., Ghasvarian, M., Ghaem, H., Alipour, H., Alipour, S., & Eftekhari, M. H. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1018357 · Cited by 31
Habets, P. C., Thomas, R. M., Milaneschi, Y., Jansen, R., Pool, R., Peyrot, W. J., Penninx, B. W. J. H., Meijer, O. C., van Wingen, G. A., & Vinkers, C. H. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.05.024 · Cited by 37
Self-citationPhysical function as predictor for the persistence of depressive and anxiety disorders
Milligen, B. A. L.-V., Vogelzangs, N., Smit, J. H., & Penninx, B. W. J. H. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.09.030 · Cited by 33
“, 2011), which also have been implicated in poorer mental health trajectories (Vogelzangs et al., 2011).”
BackgroundSelf-citationBiological rhythms, metabolic syndrome and current depressive episode in a community sample
Moreira, F. P., Jansen, K., Mondin, T. C., Cardoso, T. D. A., Magalhães, P. V. D. S., Kapczinski, F. P., Frey, B. N., Oses, J. P., Souza, L. D. D. M., da Silva, R. A., et al. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.06.007 · Cited by 28
Park, S., Joo, Y. H., McIntyre, R. S., & Kim, B. (2013) · Psychosomatics · doi:10.1016/j.psym.2013.12.010 · Cited by 24
Waist circumference and Neutrophil Gelatinase-Associated Lipocalin in late-life depression
Marijnissen, R. M., Naudé, P. J. W., Comijs, H. C., Schoevers, R. A., & Oude Voshaar, R. C. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.12.021 · Cited by 22
Increased odds of metabolic syndrome among adults with depressive symptoms or antidepressant use
Meshkat, S., Duffy, S. F., Tassone, V. K., Lin, Q., Pang, H. Y. M., Jung, H., Lou, W. Y. W., & Bhat, V. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03289-4 · Cited by 27
“The statistical analysis plan and analytic code that supports the fi ndings of this study are available from the corresponding author, VB, upon reasonable request.”
전진혁, & 김성희 (2012) · JOURNAL OF THE KOREAN SOCIETY OF MATERNAL AND CHILD HEALTH · doi:10.21896/jksmch.2012.16.2.263 · Cited by 22
de la Torre‐Luque, A., Ayuso‐Mateos, J. L., Sánchez‐Carro, Y., de la Fuente, J., & López-García, P. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104443 · Cited by 22
Sial, O. K., Gnecco, T., Cardona-Acosta, A. M., Vieregg, E., Cardoso, E. A., Parise, L. F., & Bolaños‐Guzmán, C. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.701919 · Cited by 24
Depressive symptoms are associated with poor outcome for lumbar spine surgery
Järvimäki, V., Kautiainen, H., Haanpää, M. L., Koponen, H., Spalding, M., Alahuhta, S., & Vakkala, M. A. (2016) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2016.01.008 · Cited by 20
Insulin resistance: Genetic associations with depression and cognition in population based cohorts
Frangou, S., Shirali, M., Adams, M. J., Howard, D. M., Gibson, J., Hall, L. S., Smith, B. H., Padmanabhan, S., Murray, A. D., Porteous, D. J., et al. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.04.001 · Cited by 19
“…disorder (MDD) (Kan et al., 2013) but the association with depression becomes more robust, both cross-sectionally and longitudinally, when significant dyslipidaemia is also present (Marijnissen et al., 2017; van Reedt Dortland et al., 2010; Vogelzangs et al., 2011; Vogelzangs et al., 2014).”
Dietary and metabolic risk of neuropsychiatric disorders: insights from animal models
Liang, Y., Zou, L., Tian, Y., Zhou, S., Chen, X., & Lin, C. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521000659 · Cited by 21
“At the same time, some scholars have pointed out that immune-metabolic depression is a subtypeofchronicdepression (27 – 29) .”
Bakhtiari, A., Hashemi, M., Hosseini, S. R., Omidvar, S., Bijani, A., & Khairkhah, F. (2018) · PubMed Central · Cited by 20
Hough, C. M., Bersani, F. S., Mellon, S. H., Morford, A. E., Lindqvist, D., Reus, V. I., Epel, E. S., & Wolkowitz, O. M. (2020) · Psychological Medicine · doi:10.1017/s0033291720000896 · Cited by 21
“…that MDD individuals with greater AL or MetD may represent a pathophysiological subtype of depression that may respond better to alternative treatments that specifically target AL/MetD or their mediating factors (Vogelzangs et al., 2011), although this hypothesis was not tested in this study.”
BackgroundTsenkova, V. K., & Karlamangla, A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164802 · Cited by 14
Kim, B. K., & Park, E. Y. (2020) · BMC Public Health · doi:10.1186/s12889-020-08778-3 · Cited by 18
“Instead, it has been suggested that the association between obesity and mood disorders represents a distinct condition known as metabolic–mood syndrome [13-16].”
BackgroundMajor depressive disorder and cardiometabolic disease risk among sub-Saharan African adults
Gelaye, B., Williams, M. A., Lemma, S., Berhane, Y., Fann, J. R., Stoep, A. V., & Zhou, X. (2014) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2014.05.003 · Cited by 16
“However, results have been inconclusive, and few studies have examined sub-Saharan African population [48, 51-53].”
ResultKontari, P., & Smith, K. J. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5019 · Cited by 17
Freitas, C., Deschênes, S. S., Au, B., Smith, K. J., & Schmitz, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155741 · Cited by 17
“Due to evidence suggesting that depression seems to be particularly associated with obesityrelated cardiometabolic risk factors, Vogelzangs et al [51] proposed that depression and obesity may stimulate each other’s occurrence, but once both are present, multiple progressive metabolic abnormalities may arise that incre…”
BackgroundLee, D. Y., Cho, Y. H., Kim, M.-S., Jeong, C., Cha, J. M., Won, G. H., Noh, J. S., Son, S. J., & Park, R. W. (2023) · European Psychiatry · doi:10.1192/j.eurpsy.2023.10 · Cited by 15
“Previous studies have suggested that measuring metabolic markers may be a promising way of predicting long-term clinical outcomes in depression [12].”
BackgroundGeraets, A. F. J., Schram, M. T., Jansen, J. F. A., Backes, W. H., Schalkwijk, C. G., Stehouwer, C. D. A., van Boxtel, M. P. J., Eussen, S. J. P. M., Kooman, J. P., Verhey, F. R. J., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.06.045 · Cited by 16
Cardiometabolic risk factors in patients referred to depression nurse case managers
Koponen, H., Kautiainen, H., Leppänen, E., Mäntyselkä, P. T., & Vanhala, M. J. (2014) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2014.972451 · Cited by 14
Tsang, R. S. M., Stow, D., Kwong, A. S. F., Donnelly, N. A., Fraser, H., Barroso, I., Holmans, P., Owen, M. J., Wood, M. L., Kirov, G., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03311-7 · Cited by 16
“[42, 43] The comorbidity between obesity and depression is generally associated with poorer prognosis, with studies reporting associations with a more chronic course of depression in adulthood [44, 45] as well as poorer treatment response.”
Ferri, F., Deschênes, S. S., Power, N., & Schmitz, N. (2020) · Aging & Mental Health · doi:10.1080/13607863.2020.1792412 · Cited by 13
“This has led to the identification of a subtype of depression, commonly referred to as “metabolic depression” (Vogelzangs et al., 2011).”
BackgroundPsychosocial Job Strain and Sleep Quality Interaction Leading to Insufficient Recovery
Rydstedt, L. W., & Devereux, J. J. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10115863 · Cited by 14
“Stress-induced over-activity or disturbances of the HPA system for 6 years has been related to a 6-9 fold increase in the relative risk of cardiovascular disease (CVD) depending on prior CVD history [28], cognitive impairment [29], metabolic dys-regulation [28,29], clinical depression and upper respiratory infection f…”
BackgroundYu, S., Guo, X., Li, G. X., Yang, H., Zheng, L., & Sun, Y. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02668-z · Cited by 8
The role of metabolic syndrome in late-life depression over 6 years: The NESDO study
Dekker, I. P., Marijnissen, R. M., Giltay, E. J., van der Mast, R. C., Voshaar, R. C. O., Rhebergen, D., & Ottenheim, N. R. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.07.060 · Cited by 8
“All studies used slightly different definitions for MetS (Marijnissen et al., 2017; Mulvahill et al., 2017; Vogelzangs et al., 2011).”
BackgroundMethodForbes, M., Mohebbi, M., Woods, R. L., Lotfaliany, M., Reynolds, C. F., O'Neil, A. E., McNeil, J. J., & Berk, M. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.05.014 · Cited by 7
Ruas, L. G., Diniz, B. S., Firmo, J. O. A., Peixoto, S. V., Mambrini, J. V. D. M., Filho, A. I. D. L., Lima‐Costa, M. F., & Costa, E. (2016) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2015-1856 · Cited by 8
Getting under the skin: Does biology help predict chronicity of depression?
Verhoeven, J. E., Verduijn, J., van Oppen, P., van Schaik, A., Vinkers, C. H., & Penninx, B. W. J. H. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.098 · Cited by 7
Self-citationEmerging Perspectives on Neuroprotection
Hasler, G., & Inta, D. (2024) · Psychotherapy and Psychosomatics · doi:10.1159/000540032 · Cited by 7
“To describe this comorbidity, a new distinct “ metabolic ” subtype of MDD (further mentioned as “ metabolic ” MDD ) has been proposed [60], which may overlap with atypical depression , distinct from classical melancholic depression , and characterized by hyperphagia, weight gain, hypersomnia.”
Psychiatric Disorders - New Frontiers in Affective Disorders
Schoepf, D. (2013) · InTech eBooks · doi:10.5772/2039 · Cited by 8
“Based on a community sample of older persons, (Vogelzangs et al. 2011) found that depressed subjects with metabolic syndrome (‘metabolic depression’) were almost 3-fold more likely to have persistent or recurrent depression.”
BackgroundLi, Y., Li, J., Sun, T., He, Z., Liu, C., Li, Z., Wu, Y., & Xiang, H. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02437-5 · Cited by 5
“The comorbidity of obesity and depression can lead to the prolongation and adverse outcomes of depression [31], as well as reduced adherence to obesity-related treatments [32].”
Pérez-Gutiérrez, A. M., Carmona, R., Loucera, C., Cervilla, J. A., Gutiérrez, B., Molina, E., López-López, D., Pérez-Florido, J., Zarza-Rebollo, J. A., López‐Isac, E., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02609-2 · Cited by 5
Syrogiannouli, L., Wildisen, L., Meuwese, C. L., Bauer, D. C., Cappola, A. R., Gussekloo, J., den Elzen, W. P. J., Trompet, S., Westendorp, R. G. J., Jukema, J. W., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.774251 · Cited by 5
“We saw a similar pattern for InChianti (36), where MDs were 1.78 for naïve, −2.06 for ANCOVA, −4.78 for change, and −0.28 for propensity score (lower positive values indicate better renal function).”
BackgroundResultInfluentialSelf-citationLadwig, K.-H., Marten‐Mittag, B., Olliges, E., Johar, H., Atasoy, S., Holdenrieder, S., Albus, C., Deter, H., DeZwaan, M., Fritzsche, K., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.09.146 · Cited by 5
Hühne-Landgraf, A., Laurent, K., Frisch, M. K., Wehr, M. C., Rossner, M. J., & Landgraf, D. (2023) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2023.06.002 · Cited by 5
“The phenomenon of psychiatric and metabolic comorbidity is so common that the existence of a diagnostically distinct metabolic-mood syndrome is discussed, proposing the existence of biological mechanisms underlying both conditions (5,6).”
BackgroundDepression, Vascular Conditions and Chronicity
Seldenrijk, A., Vogelzangs, N., van Oppen, P., Penninx, B. W. J. H., & van, A. B. (2013) · InTech eBooks · doi:10.5772/51623 · Cited by 4
“Based on a community sample of older persons, (Vogelzangs et al. 2011) found that depressed subjects with metabolic syndrome (‘metabolic depression’) were almost 3-fold more likely to have persistent or recurrent depression.”
BackgroundSelf-citationMetabolic syndrome among young adults at high and low familial risk for depression
Daches, S., Vértes, M., Matthews, K. A., Dósa, E., Kiss, E., Baji, I., Kapornai, K., George, C. J., & Kovács, M. (2021) · Psychological Medicine · doi:10.1017/s0033291721002907 · Cited by 4
“In the literature on the co-occurrence of depression and MetS, depression has been most commonly indexed via the number of depressive symptoms, or an overall symptom severity score, both derived from self-rated questionnaires (see also Akbaraly et al., 2009, 2011; for reviews, see Marazziti et al., 2014; Pulkki-Råback…”
BackgroundDepression and Metabolic Syndrome: Two Sides of the Same Coin
George, J., Ahmadabad, M. A., Vipin, V. P., & Eapen, V. (2019) · Journal of Biomedical and Clinical Research · doi:10.2478/jbcr-2019-0001 · Cited by 2
Porter, K. N. (2012) · Cited by 2
Wang, T. T., Zhang, M., Cao, J., Xiao, S., & Zhang, X. (2025) · Depression and Anxiety · doi:10.1155/da/9947375 · Cited by 1
“FBG abnormalities contribute to dyslipidemia in adolescents and older persons and subsequently affect thyroid function through LDL-C, HDL-C, and visceral fat, ultimately leading to depressive disorders symptoms [42, 43].”
Longpré-Poirier, C., Garel, N., Samson-Daoust, E., Page, C. L., Romain, A. J., Guay, S., Lespérance, P., & Juster, R. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120203 · Cited by 1
Oginni, O. A., Morneau‐Vaillancourt, G., Peel, A. J., Assary, E., Palaiologou, E., Lockhart, C. L., Gregory, A. M., Zavos, H. M. S., Hotopf, M. H., & Eley, T. C. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120538 · Cited by 1
“Depression in obese individuals is more likely to be resistant to antidepressant treatment alone (Vogelzangs et al., 2011).”
Physical Activity and Psychosocial Aspects of Arthritis
Katz, P. (2015) · Springer eBooks · doi:10.1007/978-3-319-22858-7_13 · Cited by 1
Lee, S.-K., Jang, Y.-E., Choi, J.-S., Shim, H.-B., & Lee, H. (2015) · 신경정신의학 · doi:10.4306/jknpa.2015.54.4.570 · Cited by 1
Ghasvarian, M., Mahboobi, S., Sadeghi, R., Ghaem, H., Hedayati, A., Alipour, S., Valisoltani, N., Harsini, A. R., & Eftekhari, M. H. (2023) · Current Functional Foods · doi:10.2174/0126668629257875230920091340 · Cited by 1
Use of antidepressants in diabetes patients not using drugs, but only monitoring blood glucose
Hundal, Ø., Biringer, E., Losnegard, I., & Lund, A. (2012) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2012.22037
“2011 [12] found that abdominal obesity; waist circumference, but not metabolic syndrome, predicted the onset of depression.”
BackgroundMechanisms Linking Depression to Cardiovascular Disease: What Do Epidemiological Studies Tell Us?
Penninx, B. W. J. H. (2016) · Springer eBooks · doi:10.1007/978-3-319-32480-7_4
Self-citationThe weight of subclinical vascular disease & neuroticism in late-life depression
Marijnissen, R. M. (2014)
Bansal, R. K., Pawar, S. K., & Sharma, V. K. (2016) · International Journal of Medical Research Professionals · doi:10.21276/ijmrp.2016.2.4.004
Obesità e spettro bipolare in pazienti con episodio depressivo maggiore (EDM)
GRAFFAGNINO, A. (2016) · Electronic Theses and Dissertations Repository (University of Pisa)
Yuan, L., Liu, J.-J., Li, Z., Zhu, Y., Ren, W., Liu, Y.-Z., Zhao, X.-L., Du, X., & Zhang, X.-Y. (2026) · World Journal of Psychiatry · doi:10.5498/wjp.v16.i2.113063
Exploring the molecular determinants of behavioral changes induced by ketamine at the nanoscale
Uyttersprot, F. (2024) · theses.fr (ABES) · doi:10.70675/df438baaz92d0z488aza38cz4227b46c9acb
Gao, Y., Li, H.-N., Li, Z.-K., Hu, J.-Z., Du, X.-Z., Yan, X., & Liu, S. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1926500
“Other cohort studies failed to identify a significant link between metabolic syndrome and depressive outcomes (19, 20).”
Metabolic alterations in adolescent psychiatric outpatients
Kurkinen, K. (2025) · UEF eRepo (University of Eastern Finland)
Metadata
- Authors
- Vogelzangs, N., Beekman, A. T. F., Boelhouwer, I. G., Bandinelli, S., Milaneschi, Y., Ferrucci, L., & Penninx, B. W. J. H.
- Affiliations
- Amsterdam Public Health (NL)
- Azienda Sanitaria di Firenze (IT)
- National Institute on Aging (US)
- National Institutes of Health (US)
- Corresponding author
- Vogelzangs, Nicole
- ORCID
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2011-04-05
- Volume
- 72
- Issue
- 05
- Pages
- 598-604
- ISSN
- 0160-6689 (ISSN-L)
- PMC
- PMC6232848
- OpenAlex
- W2007015427
- Semantic Scholar
- 735133360f5824bccb3d9ed31371623306727446
- Cited by
- 100
- References
- 52
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 5 · 2023: 6 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 7 · 2018: 8 · 2017: 4 · 2016: 12 · 2015: 5 · 2014: 7 · 2013: 12 · 2012: 7
- FWCI
- 7.08
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- VU Research Portal (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- National Institutes of Health (Z99 AG999999)
- National Heart, Lung, and Blood Institute (1 R01-HL972972)
- National Institute on Minority Health and Health Disparities (263 MD 82336, 263-MD-916413)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Social Sciences › Health › Health disparities and outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- metabolic syndrome, depression, metabolic depression, depression onset, chronic depression, waist circumference, abdominal obesity, older adults, InCHIANTI cohort, depressive symptoms, chronicity of depression
- MeSH terms
- Aged, Aged, 80 and over, Depressive Disorder, Female, Humans, Italy, Male, Prospective Studies, Psychiatric Status Rating Scales, Chi-Square Distribution, Logistic Models, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.